Form 4 for LFMD LifeMD, Inc.
Accepted 2023-11-08 00:00:00 ET · period of report 2023-11-06 · accession 0001362118-23-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-08 | 2023-11-06 | LFMD | Jindal Piyush | Dir | M - OptEx | $2.52 | +37.5K | 337.5K | +12% | +$94.5K |
| D | 2023-11-08 | 2023-11-06 | LFMD | Jindal Piyush | Dir | M - OptEx | $0.00 | -37.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-06 | M | A | 37,500 | $2.52 | 337,500 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-11-06 | M | D | 37,500 | $0.00 | 0 | D | $2.52 · — to — | 37,500 Common Stock | (F1) The options vested in four equal installments at 90, 180, 270 and 365 days from September 14, 2022, the date of grant. The option expires on September 14, 2027. |